These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12037029)

  • 21. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets.
    Derzko CM; Röhrich S; Panay N
    Menopause; 2020 Oct; 28(2):113-118. PubMed ID: 33038141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short and long-term effect of polycarbophil vaginal gel on vaginal atrophy of peri- and post-menopausal women. The TRIPLE study.
    Cagnacci A; Franco Barattini D; Casolati E; Mangrella M; Piccolo E; Piazza R; Pecoroni A; Rosu S; Cristian Pătrașcu L
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():303-308. PubMed ID: 38950453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
    Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S
    Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells.
    van der Laak JA; Schijf CP; Kerstens HM; Heijnen-Wijnen TH; de Wilde PC; Hanselaar GJ
    Cytometry; 1999 Mar; 35(3):196-202. PubMed ID: 10082300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
    Loprinzi CL; Abu-Ghazaleh S; Sloan JA; vanHaelst-Pisani C; Hammer AM; Rowland KM; Law M; Windschitl HE; Kaur JS; Ellison N
    J Clin Oncol; 1997 Mar; 15(3):969-73. PubMed ID: 9060535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
    Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
    Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
    Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
    Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D; Palacios S; Nappi RE; Mueck AO
    Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
    Lynch C
    J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
    Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
    Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Citrus Aurantium Vaginal Cream on Vaginal Atrophy in Postmenopausal Women: A Quasi-experimental Study.
    Asgharpoor H; Hadizadeh-Talasaz F; Rahmani R; Rakhshandeh H; Rahmati Z
    Int J Community Based Nurs Midwifery; 2024 Jan; 12(1):32-43. PubMed ID: 38328013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.